Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf12
|
ENSMUSG00000072294.4 | Kruppel-like factor 12 |
Klf14
|
ENSMUSG00000073209.3 | Kruppel-like factor 14 |
Sp4
|
ENSMUSG00000025323.9 | trans-acting transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_100134420_100134585 | Klf12 | 15262 | 0.243742 | 0.53 | 3.6e-05 | Click! |
chr14_99885267_99885418 | Klf12 | 15049 | 0.226894 | -0.50 | 9.3e-05 | Click! |
chr14_100132712_100132863 | Klf12 | 16977 | 0.240578 | 0.47 | 3.4e-04 | Click! |
chr14_99943203_99943598 | Klf12 | 308 | 0.936921 | -0.39 | 3.7e-03 | Click! |
chr14_100111859_100112021 | Klf12 | 37824 | 0.191144 | -0.38 | 4.4e-03 | Click! |
chr6_30959047_30959198 | Klf14 | 44 | 0.973584 | -0.51 | 7.0e-05 | Click! |
chr12_118301919_118302425 | Sp4 | 732 | 0.763917 | 0.71 | 1.4e-09 | Click! |
chr12_118301013_118301849 | Sp4 | 9 | 0.986175 | 0.68 | 1.1e-08 | Click! |
chr12_118303701_118303955 | Sp4 | 2388 | 0.390895 | 0.62 | 5.4e-07 | Click! |
chr12_118303226_118303476 | Sp4 | 1911 | 0.443914 | 0.55 | 1.6e-05 | Click! |
chr12_118300076_118300344 | Sp4 | 1158 | 0.604299 | 0.37 | 5.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_37884551_37884702 | 20.11 |
Mitd1 |
MIT, microtubule interacting and transport, domain containing 1 |
2758 |
0.16 |
chr12_105906684_105906965 | 18.56 |
Gm19554 |
predicted gene, 19554 |
6983 |
0.2 |
chr13_43261325_43261630 | 17.47 |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
41928 |
0.15 |
chr4_154882060_154882342 | 16.56 |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
8 |
0.97 |
chr10_120216764_120217346 | 16.22 |
Tmbim4 |
transmembrane BAX inhibitor motif containing 4 |
3633 |
0.18 |
chr18_12947284_12947832 | 14.01 |
Osbpl1a |
oxysterol binding protein-like 1A |
5717 |
0.19 |
chr10_80538778_80539361 | 13.47 |
Atp8b3 |
ATPase, class I, type 8B, member 3 |
21 |
0.95 |
chr14_60634308_60635258 | 12.96 |
Spata13 |
spermatogenesis associated 13 |
28 |
0.98 |
chr10_93666253_93666601 | 12.86 |
Gm8580 |
predicted gene 8580 |
581 |
0.67 |
chr12_24651648_24652438 | 12.83 |
Klf11 |
Kruppel-like factor 11 |
111 |
0.96 |
chr6_90988622_90989360 | 11.89 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
306 |
0.9 |
chr4_83623239_83623556 | 11.88 |
Gm27046 |
predicted gene, 27046 |
26094 |
0.17 |
chr5_139736302_139736636 | 11.77 |
Micall2 |
MICAL-like 2 |
133 |
0.95 |
chr9_7763414_7764605 | 11.43 |
Tmem123 |
transmembrane protein 123 |
32 |
0.97 |
chr8_120276000_120276974 | 11.35 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
48031 |
0.12 |
chr15_7998918_7999079 | 10.94 |
Gm27529 |
predicted gene, 27529 |
23670 |
0.19 |
chr8_91353182_91353359 | 10.81 |
Fto |
fat mass and obesity associated |
37285 |
0.11 |
chr14_61556175_61557459 | 10.76 |
Spryd7 |
SPRY domain containing 7 |
59 |
0.95 |
chr5_36581343_36582156 | 10.43 |
Tbc1d14 |
TBC1 domain family, member 14 |
43 |
0.97 |
chr3_89808707_89808872 | 10.08 |
Gm8969 |
predicted gene 8969 |
12209 |
0.11 |
chr10_70138201_70138471 | 9.86 |
Ccdc6 |
coiled-coil domain containing 6 |
36173 |
0.18 |
chr2_76647406_76648553 | 9.86 |
Prkra |
protein kinase, interferon inducible double stranded RNA dependent activator |
36 |
0.89 |
chr12_100958688_100959009 | 9.76 |
Ccdc88c |
coiled-coil domain containing 88C |
13675 |
0.12 |
chr9_31252507_31252669 | 9.73 |
Gm7244 |
predicted gene 7244 |
22233 |
0.14 |
chr11_74831594_74833056 | 9.70 |
Mnt |
max binding protein |
1405 |
0.31 |
chr15_72942614_72942931 | 9.68 |
Gm3150 |
predicted gene 3150 |
29415 |
0.21 |
chr5_135688462_135689288 | 9.45 |
Por |
P450 (cytochrome) oxidoreductase |
161 |
0.91 |
chr5_137600179_137600880 | 9.33 |
Mospd3 |
motile sperm domain containing 3 |
162 |
0.82 |
chr10_69910043_69910940 | 9.24 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chr8_3536176_3536342 | 9.20 |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
296 |
0.82 |
chr2_24934550_24935930 | 9.15 |
Arrdc1 |
arrestin domain containing 1 |
12 |
0.94 |
chr6_86660191_86660348 | 9.10 |
Mxd1 |
MAX dimerization protein 1 |
2836 |
0.15 |
chr1_192092498_192092871 | 8.97 |
Traf5 |
TNF receptor-associated factor 5 |
125 |
0.74 |
chr16_18036491_18036724 | 8.90 |
Gm49580 |
predicted gene, 49580 |
7928 |
0.13 |
chr4_43039553_43040518 | 8.88 |
Fam214b |
family with sequence similarity 214, member B |
253 |
0.85 |
chr1_36090745_36091181 | 8.82 |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
10727 |
0.14 |
chr10_75517294_75517708 | 8.76 |
Snrpd3 |
small nuclear ribonucleoprotein D3 |
50 |
0.58 |
chr1_160905998_160906469 | 8.75 |
Rc3h1 |
RING CCCH (C3H) domains 1 |
185 |
0.88 |
chr4_135272877_135273236 | 8.63 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
242 |
0.9 |
chr3_52985507_52985880 | 8.58 |
Cog6 |
component of oligomeric golgi complex 6 |
8992 |
0.16 |
chr8_122323502_122324203 | 8.55 |
Zfpm1 |
zinc finger protein, multitype 1 |
9846 |
0.13 |
chr8_107030704_107031406 | 8.54 |
Gm16208 |
predicted gene 16208 |
133 |
0.53 |
chr14_20793233_20794132 | 8.31 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr7_16874715_16875380 | 8.30 |
9330104G04Rik |
RIKEN cDNA 9330104G04 gene |
161 |
0.62 |
chr5_111239248_111239612 | 8.24 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4115 |
0.24 |
chr10_111164274_111164899 | 8.14 |
Osbpl8 |
oxysterol binding protein-like 8 |
166 |
0.93 |
chr17_27826103_27826412 | 8.13 |
Ilrun |
inflammation and lipid regulator with UBA-like and NBR1-like domains |
5609 |
0.13 |
chr16_87698379_87699046 | 8.10 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
233 |
0.94 |
chr10_80080768_80080945 | 8.07 |
Sbno2 |
strawberry notch 2 |
5417 |
0.1 |
chr19_17323116_17323284 | 8.00 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
12236 |
0.21 |
chr15_75886612_75887093 | 7.98 |
Mroh6 |
maestro heat-like repeat family member 6 |
1918 |
0.15 |
chr4_117836215_117836800 | 7.93 |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
1069 |
0.38 |
chr9_66896128_66896299 | 7.91 |
Rab8b |
RAB8B, member RAS oncogene family |
23474 |
0.14 |
chr10_126978437_126978657 | 7.87 |
Ctdsp2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
170 |
0.89 |
chr18_12936088_12936279 | 7.87 |
Osbpl1a |
oxysterol binding protein-like 1A |
5594 |
0.19 |
chr15_96709352_96710351 | 7.77 |
Gm38144 |
predicted gene, 38144 |
9678 |
0.18 |
chr3_142881840_142882567 | 7.77 |
Pkn2 |
protein kinase N2 |
199 |
0.55 |
chr14_69540059_69540582 | 7.70 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr14_69321815_69322332 | 7.70 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr16_93711386_93712056 | 7.70 |
Dop1b |
DOP1 leucine zipper like protein B |
183 |
0.93 |
chr17_65951071_65951709 | 7.70 |
Twsg1 |
twisted gastrulation BMP signaling modulator 1 |
164 |
0.94 |
chr6_48086477_48087095 | 7.62 |
Zfp746 |
zinc finger protein 746 |
193 |
0.93 |
chr9_57076487_57077201 | 7.60 |
Sin3a |
transcriptional regulator, SIN3A (yeast) |
216 |
0.9 |
chr3_144720129_144720738 | 7.56 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
98 |
0.95 |
chr6_146642284_146642692 | 7.55 |
Med21 |
mediator complex subunit 21 |
59 |
0.81 |
chr2_121008071_121008912 | 7.53 |
Ccndbp1 |
cyclin D-type binding-protein 1 |
19 |
0.96 |
chr17_17373690_17374333 | 7.51 |
AC154200.1 |
novel transcript |
195 |
0.62 |
chr10_122096764_122097910 | 7.46 |
Rxylt1 |
ribitol xylosyltransferase 1 |
34 |
0.97 |
chr7_63938917_63939336 | 7.42 |
Klf13 |
Kruppel-like factor 13 |
211 |
0.91 |
chr6_52011992_52012826 | 7.40 |
Skap2 |
src family associated phosphoprotein 2 |
106 |
0.62 |
chr10_81378065_81379152 | 7.28 |
Fzr1 |
fizzy and cell division cycle 20 related 1 |
92 |
0.89 |
chr10_80569782_80569989 | 7.26 |
Klf16 |
Kruppel-like factor 16 |
7436 |
0.08 |
chr4_130252878_130253050 | 7.26 |
Serinc2 |
serine incorporator 2 |
22254 |
0.14 |
chr5_124095656_124096251 | 7.17 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
155 |
0.91 |
chr19_24961254_24961969 | 7.16 |
Cbwd1 |
COBW domain containing 1 |
1 |
0.97 |
chr11_117792296_117792500 | 7.15 |
Gm11724 |
predicted gene 11724 |
1085 |
0.24 |
chr17_56716558_56717196 | 7.15 |
Vmac |
vimentin-type intermediate filament associated coiled-coil protein |
100 |
0.9 |
chr11_109611544_109612115 | 6.88 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
138 |
0.95 |
chr6_125095392_125097556 | 6.85 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr14_31110708_31110879 | 6.84 |
Smim4 |
small integral membrane protein 4 |
18045 |
0.09 |
chr14_53337554_53337726 | 6.81 |
Gm43650 |
predicted gene 43650 |
6282 |
0.19 |
chr10_59951802_59952780 | 6.80 |
Ddit4 |
DNA-damage-inducible transcript 4 |
457 |
0.81 |
chr9_99248394_99248720 | 6.77 |
Cep70 |
centrosomal protein 70 |
2270 |
0.17 |
chr6_144901953_144902113 | 6.75 |
Gm22792 |
predicted gene, 22792 |
98401 |
0.06 |
chr9_64049851_64050017 | 6.70 |
Gm25606 |
predicted gene, 25606 |
1438 |
0.31 |
chr6_87775979_87776163 | 6.68 |
Gm43904 |
predicted gene, 43904 |
72 |
0.92 |
chr14_53729986_53730169 | 6.67 |
Trav13-3 |
T cell receptor alpha variable 13-3 |
519 |
0.72 |
chr10_44164343_44164520 | 6.66 |
Speer5-ps1 |
spermatogenesis associated glutamate (E)-rich protein 5, pseudogene 1 |
5480 |
0.16 |
chr13_58476056_58476438 | 6.65 |
Gm47918 |
predicted gene, 47918 |
33226 |
0.13 |
chr13_111656903_111657234 | 6.63 |
Mier3 |
MIER family member 3 |
23911 |
0.13 |
chr12_111442215_111442766 | 6.62 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
21 |
0.96 |
chr7_24610450_24611460 | 6.56 |
Phldb3 |
pleckstrin homology like domain, family B, member 3 |
192 |
0.87 |
chr18_67449093_67449557 | 6.53 |
Afg3l2 |
AFG3-like AAA ATPase 2 |
153 |
0.94 |
chr1_195092219_195092480 | 6.52 |
Cd46 |
CD46 antigen, complement regulatory protein |
100 |
0.95 |
chr11_121203924_121204680 | 6.52 |
Hexdc |
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing |
131 |
0.78 |
chr4_57955999_57956932 | 6.47 |
Txn1 |
thioredoxin 1 |
54 |
0.98 |
chr11_121420955_121421495 | 6.36 |
Fn3krp |
fructosamine 3 kinase related protein |
176 |
0.92 |
chr3_97657928_97658413 | 6.35 |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
23 |
0.97 |
chr5_110809790_110810382 | 6.34 |
Ulk1 |
unc-51 like kinase 1 |
11 |
0.96 |
chr14_53033253_53033591 | 6.31 |
Gm30214 |
predicted gene, 30214 |
6044 |
0.17 |
chr11_97884065_97884612 | 6.31 |
Fbxo47 |
F-box protein 47 |
184 |
0.58 |
chr17_47909349_47909983 | 6.30 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr7_6362861_6363103 | 6.28 |
Zfp78 |
zinc finger protein 78 |
298 |
0.78 |
chr2_155613495_155613697 | 6.27 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2384 |
0.13 |
chr1_135941719_135941893 | 6.26 |
Igfn1 |
immunoglobulin-like and fibronectin type III domain containing 1 |
21334 |
0.13 |
chr1_58993264_58993423 | 6.16 |
Stradb |
STE20-related kinase adaptor beta |
2285 |
0.22 |
chr10_91082840_91083131 | 6.13 |
Ikbip |
IKBKB interacting protein |
45 |
0.72 |
chr4_155563302_155563634 | 6.12 |
Nadk |
NAD kinase |
232 |
0.87 |
chr1_184631188_184631352 | 6.09 |
Gm37800 |
predicted gene, 37800 |
1797 |
0.31 |
chr5_105526137_105526288 | 6.04 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
6739 |
0.2 |
chr2_104122426_104123415 | 6.02 |
A930018P22Rik |
RIKEN cDNA A930018P22 gene |
151 |
0.94 |
chr8_121578951_121579579 | 5.99 |
Fbxo31 |
F-box protein 31 |
459 |
0.69 |
chr5_137569704_137569886 | 5.99 |
Tfr2 |
transferrin receptor 2 |
45 |
0.93 |
chr8_46617194_46618101 | 5.98 |
Casp3 |
caspase 3 |
205 |
0.72 |
chr7_118243052_118244285 | 5.97 |
Smg1 |
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
2 |
0.72 |
chr7_52006002_52006720 | 5.97 |
Svip |
small VCP/p97-interacting protein |
343 |
0.87 |
chr5_92137605_92138024 | 5.96 |
Uso1 |
USO1 vesicle docking factor |
124 |
0.94 |
chr10_77301012_77301180 | 5.95 |
Pofut2 |
protein O-fucosyltransferase 2 |
34179 |
0.13 |
chr11_78751606_78751883 | 5.93 |
Ccnq |
cyclin Q |
15 |
0.97 |
chr4_153670421_153670572 | 5.92 |
Ajap1 |
adherens junction associated protein 1 |
187685 |
0.03 |
chr4_136021652_136022029 | 5.89 |
Eloa |
elongin A |
77 |
0.94 |
chr11_4217876_4218712 | 5.89 |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
69 |
0.94 |
chr8_95593910_95594144 | 5.88 |
Gm31518 |
predicted gene, 31518 |
505 |
0.66 |
chr9_70656693_70657571 | 5.84 |
Mindy2 |
MINDY lysine 48 deubiquitinase 2 |
15 |
0.95 |
chr15_78405589_78406226 | 5.83 |
Tst |
thiosulfate sulfurtransferase, mitochondrial |
0 |
0.88 |
chr5_139803700_139803926 | 5.83 |
Tmem184a |
transmembrane protein 184a |
4167 |
0.14 |
chr4_48124809_48125003 | 5.79 |
Stx17 |
syntaxin 17 |
9 |
0.98 |
chrX_135086698_135087181 | 5.79 |
3632454L22Rik |
RIKEN cDNA 3632454L22 gene |
26603 |
0.13 |
chr15_63997975_63998392 | 5.73 |
Fam49b |
family with sequence similarity 49, member B |
214 |
0.93 |
chr13_92354947_92355242 | 5.72 |
Msh3 |
mutS homolog 3 |
91 |
0.82 |
chr8_122174145_122174505 | 5.70 |
Zfp469 |
zinc finger protein 469 |
84295 |
0.07 |
chr5_114826252_114826541 | 5.68 |
Ywhaq-ps2 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta, pseudogene 2 |
2819 |
0.11 |
chr19_4097495_4097977 | 5.68 |
Cdk2ap2 |
CDK2-associated protein 2 |
334 |
0.66 |
chr17_6317251_6317667 | 5.68 |
Dynlt1a |
dynein light chain Tctex-type 1A |
41 |
0.96 |
chr1_167349839_167350315 | 5.65 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
86 |
0.93 |
chr2_29869313_29870035 | 5.64 |
Cercam |
cerebral endothelial cell adhesion molecule |
130 |
0.85 |
chr11_117027778_117027957 | 5.63 |
Gm11728 |
predicted gene 11728 |
12321 |
0.12 |
chr12_4873957_4874552 | 5.61 |
Mfsd2b |
major facilitator superfamily domain containing 2B |
91 |
0.95 |
chr12_72085046_72085908 | 5.57 |
L3hypdh |
L-3-hydroxyproline dehydratase (trans-) |
38 |
0.58 |
chr19_17356537_17356750 | 5.54 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
24 |
0.98 |
chr6_30896710_30897292 | 5.46 |
4930412F09Rik |
RIKEN cDNA 4930412F09 gene |
102 |
0.65 |
chr8_23028271_23028847 | 5.40 |
Ank1 |
ankyrin 1, erythroid |
6540 |
0.2 |
chr8_69974221_69974915 | 5.40 |
Gatad2a |
GATA zinc finger domain containing 2A |
297 |
0.85 |
chr19_36409278_36410322 | 5.37 |
Pcgf5 |
polycomb group ring finger 5 |
52 |
0.97 |
chr8_108820727_108820921 | 5.34 |
Gm38318 |
predicted gene, 38318 |
46738 |
0.15 |
chr11_97427734_97428829 | 5.34 |
Arhgap23 |
Rho GTPase activating protein 23 |
8004 |
0.16 |
chr5_33629478_33629976 | 5.33 |
Fam53a |
family with sequence similarity 53, member A |
92 |
0.64 |
chr11_116624141_116624473 | 5.32 |
Rhbdf2 |
rhomboid 5 homolog 2 |
60 |
0.95 |
chr15_36647396_36647566 | 5.32 |
Gm6704 |
predicted gene 6704 |
17612 |
0.12 |
chr6_120665862_120666733 | 5.30 |
Cecr2 |
CECR2, histone acetyl-lysine reader |
72 |
0.98 |
chr2_118388313_118388716 | 5.28 |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
104 |
0.96 |
chr10_128094701_128094885 | 5.28 |
Baz2a |
bromodomain adjacent to zinc finger domain, 2A |
1587 |
0.17 |
chr12_76930300_76930461 | 5.27 |
Max |
Max protein |
9614 |
0.16 |
chr11_100938783_100940230 | 5.26 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr7_96705482_96705807 | 5.26 |
Tenm4 |
teneurin transmembrane protein 4 |
61472 |
0.11 |
chr3_38484735_38485121 | 5.26 |
Ankrd50 |
ankyrin repeat domain 50 |
84 |
0.97 |
chr5_120612804_120613204 | 5.24 |
Ddx54 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 |
123 |
0.78 |
chrX_150547265_150547522 | 5.24 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
18 |
0.52 |
chr7_16313509_16314466 | 5.24 |
Bbc3 |
BCL2 binding component 3 |
470 |
0.71 |
chr16_90810337_90810721 | 5.23 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
116 |
0.95 |
chr7_126042390_126042861 | 5.23 |
Gm44874 |
predicted gene 44874 |
21822 |
0.17 |
chr6_49367200_49368123 | 5.22 |
Fam221a |
family with sequence similarity 221, member A |
78 |
0.97 |
chr8_70700546_70701138 | 5.21 |
Gm11175 |
predicted gene 11175 |
762 |
0.36 |
chr1_134747636_134747798 | 5.21 |
Syt2 |
synaptotagmin II |
860 |
0.55 |
chrY_90739614_90740540 | 5.19 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr2_32132655_32133064 | 5.16 |
Prrc2b |
proline-rich coiled-coil 2B |
18223 |
0.11 |
chr9_120110678_120110975 | 5.14 |
Slc25a38 |
solute carrier family 25, member 38 |
402 |
0.67 |
chr10_117845907_117846245 | 5.13 |
Rap1b |
RAS related protein 1b |
41 |
0.97 |
chr7_83885330_83885500 | 5.13 |
Mesd |
mesoderm development LRP chaperone |
949 |
0.31 |
chr2_93461958_93462733 | 5.13 |
Cd82 |
CD82 antigen |
41 |
0.97 |
chr7_99828287_99828495 | 5.09 |
Neu3 |
neuraminidase 3 |
26 |
0.96 |
chr3_88532663_88533971 | 5.08 |
Mex3a |
mex3 RNA binding family member A |
922 |
0.31 |
chr7_4685168_4685353 | 5.08 |
Hspbp1 |
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
192 |
0.86 |
chr5_73256580_73257031 | 5.08 |
Fryl |
FRY like transcription coactivator |
186 |
0.9 |
chr5_134688076_134689277 | 5.02 |
Limk1 |
LIM-domain containing, protein kinase |
78 |
0.96 |
chr17_84879231_84879533 | 5.01 |
Gm49982 |
predicted gene, 49982 |
23187 |
0.14 |
chr2_72196283_72196475 | 5.01 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
2420 |
0.29 |
chr12_4817372_4817571 | 4.95 |
Sf3b6 |
splicing factor 3B, subunit 6 |
73 |
0.95 |
chr2_131909652_131910478 | 4.94 |
Prn |
prion protein readthrough transcript |
108 |
0.51 |
chr16_90740115_90740266 | 4.94 |
Mrap |
melanocortin 2 receptor accessory protein |
1866 |
0.27 |
chr4_155066765_155067549 | 4.94 |
Pex10 |
peroxisomal biogenesis factor 10 |
98 |
0.95 |
chr6_137754442_137754649 | 4.93 |
Dera |
deoxyribose-phosphate aldolase (putative) |
1 |
0.98 |
chr9_110131800_110132613 | 4.92 |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
169 |
0.93 |
chr2_156494879_156495181 | 4.91 |
Epb41l1 |
erythrocyte membrane protein band 4.1 like 1 |
11364 |
0.13 |
chr4_52438875_52439051 | 4.89 |
Smc2os |
structural maintenance of chromosomes 2, opposite strand |
2 |
0.8 |
chr10_41912421_41912601 | 4.89 |
Sesn1 |
sestrin 1 |
14138 |
0.21 |
chr7_16272790_16273535 | 4.86 |
Inafm1 |
InaF motif containing 1 |
455 |
0.67 |
chr7_114275561_114276736 | 4.86 |
Psma1 |
proteasome subunit alpha 1 |
30 |
0.98 |
chr5_147076781_147077681 | 4.86 |
Polr1d |
polymerase (RNA) I polypeptide D |
115 |
0.89 |
chr7_127776501_127776684 | 4.85 |
Setd1a |
SET domain containing 1A |
78 |
0.92 |
chr2_153492229_153493481 | 4.84 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr5_91963026_91963464 | 4.84 |
Thap6 |
THAP domain containing 6 |
88 |
0.62 |
chr8_94733906_94734089 | 4.83 |
Ccl22 |
chemokine (C-C motif) ligand 22 |
11593 |
0.12 |
chr1_180255528_180256861 | 4.78 |
Psen2 |
presenilin 2 |
50 |
0.74 |
chr7_141454780_141455220 | 4.77 |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
198 |
0.81 |
chr10_80168473_80168694 | 4.76 |
Cirbp |
cold inducible RNA binding protein |
697 |
0.44 |
chr17_25222083_25222713 | 4.75 |
Unkl |
unkempt family like zinc finger |
141 |
0.9 |
chr4_106678863_106679149 | 4.74 |
Ttc4 |
tetratricopeptide repeat domain 4 |
62 |
0.96 |
chrX_100626534_100626699 | 4.73 |
Pdzd11 |
PDZ domain containing 11 |
48 |
0.93 |
chr10_81106102_81106421 | 4.73 |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
84 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.4 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
4.2 | 12.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
3.7 | 11.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
3.4 | 10.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
3.2 | 9.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.7 | 8.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
2.3 | 6.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.3 | 2.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.3 | 11.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
2.3 | 6.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.2 | 8.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.2 | 8.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.1 | 6.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
2.1 | 6.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
2.0 | 6.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.0 | 6.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.0 | 6.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.0 | 2.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.9 | 3.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.9 | 5.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.9 | 7.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.8 | 5.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.8 | 5.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.8 | 5.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.8 | 3.6 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.8 | 5.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.8 | 5.4 | GO:0002432 | granuloma formation(GO:0002432) |
1.8 | 19.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.8 | 5.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.8 | 5.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.8 | 5.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.7 | 5.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.7 | 10.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.7 | 19.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.7 | 8.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.7 | 1.7 | GO:0070627 | ferrous iron import(GO:0070627) |
1.7 | 10.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.7 | 11.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.7 | 6.7 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.7 | 6.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.6 | 4.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.6 | 8.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.6 | 4.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.6 | 3.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.6 | 3.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.6 | 6.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.6 | 15.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.6 | 3.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.6 | 4.7 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.6 | 4.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.5 | 9.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.5 | 3.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.5 | 4.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 7.5 | GO:0072553 | terminal button organization(GO:0072553) |
1.5 | 4.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.5 | 4.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.5 | 4.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.4 | 4.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.4 | 4.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.4 | 11.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.4 | 4.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.4 | 8.5 | GO:0016266 | O-glycan processing(GO:0016266) |
1.4 | 4.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.4 | 2.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.4 | 4.2 | GO:0040031 | snRNA modification(GO:0040031) |
1.4 | 4.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.4 | 4.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.4 | 8.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.4 | 4.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.4 | 4.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.4 | 9.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.4 | 4.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.4 | 9.5 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.4 | 5.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.3 | 12.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.3 | 10.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.3 | 4.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.3 | 4.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.3 | 2.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.3 | 7.9 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
1.3 | 7.9 | GO:0051013 | microtubule severing(GO:0051013) |
1.3 | 2.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.3 | 6.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.3 | 2.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.3 | 5.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.3 | 5.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.3 | 1.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.3 | 6.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 3.8 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.3 | 16.6 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.3 | 1.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.3 | 5.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.3 | 6.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.3 | 3.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
1.3 | 5.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.2 | 1.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.2 | 7.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.2 | 4.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.2 | 13.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.2 | 3.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.2 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.2 | 8.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.2 | 3.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.2 | 3.6 | GO:0015888 | thiamine transport(GO:0015888) |
1.2 | 6.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.2 | 4.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.2 | 2.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.2 | 4.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.2 | 3.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.2 | 5.9 | GO:0060789 | hair follicle placode formation(GO:0060789) |
1.2 | 3.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.2 | 3.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.2 | 4.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.2 | 4.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.2 | 5.8 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.2 | 1.2 | GO:0006573 | valine metabolic process(GO:0006573) |
1.2 | 2.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.2 | 2.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.2 | 3.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.2 | 2.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
1.2 | 9.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.1 | 1.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.1 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.1 | 8.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.1 | 3.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 4.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.1 | 2.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.1 | 3.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.1 | 3.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.1 | 3.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.1 | 6.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.1 | 6.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.1 | 3.3 | GO:0019086 | late viral transcription(GO:0019086) |
1.1 | 4.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.1 | 2.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 3.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.1 | 9.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.1 | 5.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.1 | 13.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.1 | 3.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
1.1 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.1 | 4.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.1 | 2.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.1 | 11.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.1 | 3.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.1 | 4.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.1 | 2.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.1 | 4.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.1 | 4.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.1 | 1.1 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
1.1 | 5.3 | GO:0036233 | glycine import(GO:0036233) |
1.1 | 9.5 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
1.0 | 5.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.0 | 3.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 3.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.0 | 2.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.0 | 3.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.0 | 4.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.0 | 12.3 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.0 | 2.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.0 | 1.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.0 | 3.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.0 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.0 | 3.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.0 | 1.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.0 | 3.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.0 | 3.0 | GO:0000087 | mitotic M phase(GO:0000087) |
1.0 | 4.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.0 | 8.0 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
1.0 | 3.0 | GO:0051182 | coenzyme transport(GO:0051182) |
1.0 | 3.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
1.0 | 5.9 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.0 | 2.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.0 | 2.9 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.0 | 7.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.0 | 2.9 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
1.0 | 6.8 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
1.0 | 3.9 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.0 | 3.9 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.0 | 4.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.0 | 1.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.0 | 2.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.0 | 3.8 | GO:0007097 | nuclear migration(GO:0007097) |
1.0 | 2.9 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.9 | 5.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.9 | 4.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.9 | 1.9 | GO:1901660 | calcium ion export(GO:1901660) |
0.9 | 4.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.9 | 8.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.9 | 5.7 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.9 | 2.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.9 | 3.7 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.9 | 13.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 8.3 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.9 | 9.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 2.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 4.6 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.9 | 4.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.9 | 10.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 14.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.9 | 2.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.9 | 2.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.9 | 4.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.9 | 3.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.9 | 8.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.9 | 13.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.9 | 5.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.9 | 0.9 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.9 | 20.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.9 | 3.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.9 | 6.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.9 | 1.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.9 | 2.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 3.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.9 | 1.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.9 | 4.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.9 | 1.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.9 | 11.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 3.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.8 | 6.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.8 | 1.7 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.8 | 2.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.8 | 2.5 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.8 | 2.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 3.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 5.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.8 | 3.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 3.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.8 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.8 | 4.9 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.8 | 4.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.8 | 2.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.8 | 2.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 4.1 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.8 | 3.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.8 | 4.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.8 | 3.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.8 | 2.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 2.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.8 | 0.8 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.8 | 4.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 0.8 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.8 | 4.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.8 | 2.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.8 | 1.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.8 | 2.4 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.8 | 2.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 3.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 2.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.8 | 1.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.8 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.8 | 4.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.8 | 3.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.8 | 1.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 5.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.8 | 3.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.8 | 9.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.8 | 5.3 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.8 | 3.0 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.8 | 20.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.8 | 3.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.8 | 2.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.8 | 4.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.8 | 3.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.8 | 3.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.7 | 2.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.7 | 3.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 3.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.7 | 6.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.7 | 5.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.7 | 3.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.7 | 2.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.7 | 2.9 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.7 | 2.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 1.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.7 | 3.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 5.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.7 | 3.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 1.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.7 | 1.4 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.7 | 20.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.7 | 4.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 0.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.7 | 5.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.7 | 4.3 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.7 | 9.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.7 | 3.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.7 | 3.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.7 | 2.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.7 | 0.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 0.7 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.7 | 2.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.7 | 4.9 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.7 | 8.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.7 | 4.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.7 | 4.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.7 | 2.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.7 | 2.8 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.7 | 1.4 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.7 | 9.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.7 | 2.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.7 | 6.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 0.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 2.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.7 | 2.1 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 4.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.7 | 3.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 1.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 2.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.7 | 1.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.7 | 4.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 0.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.7 | 2.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 4.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.7 | 2.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.7 | 3.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 0.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.7 | 1.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.7 | 5.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.7 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.7 | 6.7 | GO:0042407 | cristae formation(GO:0042407) |
0.7 | 2.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 4.0 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.7 | 4.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 2.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 2.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 1.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.7 | 4.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.7 | 2.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.7 | 1.3 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.7 | 3.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 6.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 3.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.7 | 1.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.7 | 2.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.6 | 4.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.6 | 3.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 1.9 | GO:0009838 | abscission(GO:0009838) |
0.6 | 1.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.6 | 3.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.6 | 2.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 0.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.6 | 1.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.6 | 1.9 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.6 | 5.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.6 | 1.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.6 | 1.9 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 1.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 3.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.6 | 7.4 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.6 | 2.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 0.6 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.6 | 3.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.6 | 8.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.6 | 1.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.6 | 0.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.6 | 3.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 4.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 1.2 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.6 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.6 | 2.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.6 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 0.6 | GO:0045472 | response to ether(GO:0045472) |
0.6 | 1.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 1.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.6 | 4.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 1.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 2.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 2.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 3.0 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.6 | 7.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.6 | 4.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.6 | 2.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 2.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 3.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 2.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 2.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 2.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 1.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.6 | 3.5 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.6 | 2.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 2.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.6 | 1.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.6 | 1.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 2.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 2.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 1.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.6 | 4.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 7.5 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.6 | 0.6 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.6 | 1.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 3.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 7.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 3.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.6 | 1.7 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.6 | 4.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.6 | 1.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 2.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.6 | 5.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.6 | 5.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 4.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.6 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 5.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 2.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.6 | 1.7 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.6 | 1.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.6 | 2.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 1.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.6 | 2.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 1.7 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.6 | 8.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 1.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.6 | 1.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 2.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 6.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.6 | 3.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 1.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 4.9 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.5 | 16.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 4.9 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.5 | 4.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 2.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 5.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.5 | 1.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 2.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.5 | 1.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 1.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 2.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.5 | 1.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.5 | 2.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 4.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 1.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.5 | 1.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 4.2 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.5 | 1.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 9.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 4.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.5 | 16.6 | GO:0043297 | apical junction assembly(GO:0043297) |
0.5 | 1.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.5 | 1.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.5 | 4.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 3.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 1.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 5.1 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.5 | 2.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.5 | 1.5 | GO:0019042 | viral latency(GO:0019042) |
0.5 | 1.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.5 | 5.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.5 | 3.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 3.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 1.0 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 2.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 3.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 17.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.5 | 2.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 10.9 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.5 | 1.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.5 | 1.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 2.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 0.5 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.5 | 2.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.5 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.5 | 1.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.5 | 1.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 2.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 3.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 2.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.5 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 1.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.5 | 1.0 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.5 | 1.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 1.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.5 | 3.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.5 | 3.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 3.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 1.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 2.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.5 | 3.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.5 | 0.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.5 | 1.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.5 | 1.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.5 | 1.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 1.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 0.9 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.5 | 5.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.5 | 4.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 1.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 1.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 0.5 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.5 | 1.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 0.5 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.5 | 5.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 1.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.5 | 0.9 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 2.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.5 | 15.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.5 | 1.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 0.5 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.5 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 6.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 1.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 0.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 0.4 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.4 | 0.4 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.4 | 1.8 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.4 | 2.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 0.9 | GO:0015793 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.4 | 1.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.4 | 1.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 2.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 0.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.4 | 1.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 5.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 6.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 0.4 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.4 | 3.9 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.4 | 0.9 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 5.6 | GO:0007099 | centriole replication(GO:0007099) |
0.4 | 4.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 0.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.4 | 0.9 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 1.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 0.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.4 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 3.4 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.4 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 1.7 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.4 | 7.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.4 | 2.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 1.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.4 | 1.7 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 1.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 1.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 3.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 0.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 1.6 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.4 | 1.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.4 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.4 | 1.2 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 0.8 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 0.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 1.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 0.4 | GO:0051029 | rRNA transport(GO:0051029) |
0.4 | 0.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 2.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.4 | 0.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.4 | 0.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 1.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 2.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 2.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 2.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.4 | 14.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.4 | 2.3 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.4 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 3.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 6.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 1.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 12.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 0.4 | GO:0061010 | gall bladder development(GO:0061010) |
0.4 | 3.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.4 | 1.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 1.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 0.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.4 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 0.8 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.4 | 1.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 0.4 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.4 | 2.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 9.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.4 | 1.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 2.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 0.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 0.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 0.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.4 | 0.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.4 | 1.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 1.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 3.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 0.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 4.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 5.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 1.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 2.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 0.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 0.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.4 | 1.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.4 | 0.4 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.4 | 2.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 0.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 1.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 1.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 1.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.8 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.3 | 5.9 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 0.7 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 3.8 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 3.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 2.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 5.5 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 5.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 0.7 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 1.0 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 1.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 2.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 1.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 2.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 11.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 3.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 0.7 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.0 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 1.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.3 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 1.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 0.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 1.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 4.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 1.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 0.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 8.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 1.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.3 | 4.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 3.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.3 | GO:0010742 | macrophage derived foam cell differentiation(GO:0010742) |
0.3 | 1.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 2.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 4.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 2.5 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.3 | 0.6 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.3 | 1.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 5.6 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.3 | 3.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 5.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 5.5 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 0.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.3 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 2.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.6 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.3 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.3 | 10.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 1.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.3 | 0.9 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 6.3 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 8.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 9.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 1.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 2.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 2.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 0.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 2.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 1.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 5.2 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 3.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 12.1 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.3 | 17.8 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 0.9 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.3 | 6.6 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 4.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 3.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 1.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 1.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 0.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 1.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 0.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 2.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 2.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 1.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.5 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 6.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 2.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 1.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 3.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 1.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 1.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 1.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 2.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.3 | GO:0043038 | amino acid activation(GO:0043038) |
0.3 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 1.3 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.3 | 3.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.8 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.3 | 1.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.8 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.3 | 0.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.5 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.6 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 1.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 1.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 0.5 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 1.9 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.3 | 1.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 9.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.3 | 0.8 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 1.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.5 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.5 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 1.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.3 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.3 | 2.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 1.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 8.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.3 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.3 | 1.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 0.5 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.3 | 0.8 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 2.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 1.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.3 | 1.3 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.3 | 1.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 1.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.0 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 1.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.2 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 3.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 4.4 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 1.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 3.6 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 1.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 1.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.4 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 1.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 2.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.2 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.7 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.8 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 3.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 5.9 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 2.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 1.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 1.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 1.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 3.1 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 1.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.2 | 4.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 3.3 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 15.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 0.8 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 2.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 2.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 5.3 | GO:0051297 | centrosome organization(GO:0051297) |
0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 1.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 0.6 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 4.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.4 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.2 | 1.8 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.8 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 2.0 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.2 | 0.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 1.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 2.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 2.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 1.5 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 0.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.4 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 5.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 0.9 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 2.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.4 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 8.2 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 0.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.5 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.2 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
0.2 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 1.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 4.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 1.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 2.7 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.2 | 0.2 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.2 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.2 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.2 | 0.2 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.2 | 4.6 | GO:0036503 | ERAD pathway(GO:0036503) |
0.2 | 0.5 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.2 | 0.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.2 | 1.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 1.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.2 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.2 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 1.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 3.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 1.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.9 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.6 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.3 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 2.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.4 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.7 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 2.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 7.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 2.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 1.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 2.0 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 2.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 1.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 1.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.4 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 1.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 5.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.6 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 2.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 3.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.7 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 1.4 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 3.0 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 1.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 1.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.7 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 1.9 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 4.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 3.0 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.1 | 0.1 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 4.1 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.4 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.1 | 1.8 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 4.7 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 2.7 | GO:0009205 | ribonucleoside triphosphate metabolic process(GO:0009199) purine ribonucleoside triphosphate metabolic process(GO:0009205) |
0.1 | 0.5 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.4 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 4.4 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.2 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.1 | 0.6 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.7 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.4 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 2.5 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 1.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 1.0 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.9 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.1 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.6 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 1.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 5.5 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.9 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.3 | GO:0071426 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 1.0 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 1.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.6 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.6 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.2 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.1 | 0.6 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.1 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.3 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:1902308 | peptidyl-serine dephosphorylation(GO:0070262) regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.5 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 1.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.3 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.9 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.0 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.8 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 7.9 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.6 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.4 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.0 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.0 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.0 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.0 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.0 | 0.0 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.1 | GO:0009116 | nucleoside metabolic process(GO:0009116) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0072110 | glomerular mesangial cell proliferation(GO:0072110) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.4 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.0 | GO:0019076 | viral release from host cell(GO:0019076) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 3.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
2.5 | 10.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.3 | 9.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.2 | 6.7 | GO:0005745 | m-AAA complex(GO:0005745) |
2.2 | 6.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.1 | 6.3 | GO:0043293 | apoptosome(GO:0043293) |
2.0 | 6.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.9 | 28.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.8 | 8.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.7 | 6.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.6 | 6.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.5 | 7.4 | GO:0005683 | U7 snRNP(GO:0005683) |
1.4 | 4.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.4 | 15.6 | GO:0016580 | Sin3 complex(GO:0016580) |
1.4 | 13.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.3 | 3.9 | GO:0000811 | GINS complex(GO:0000811) |
1.3 | 3.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.2 | 3.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.2 | 3.7 | GO:0055087 | Ski complex(GO:0055087) |
1.2 | 3.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.2 | 4.9 | GO:0042825 | TAP complex(GO:0042825) |
1.2 | 9.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.2 | 9.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.2 | 9.4 | GO:0000812 | Swr1 complex(GO:0000812) |
1.2 | 7.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.2 | 8.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.2 | 4.6 | GO:0032021 | NELF complex(GO:0032021) |
1.1 | 4.6 | GO:0071797 | LUBAC complex(GO:0071797) |
1.1 | 3.4 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 5.4 | GO:0000235 | astral microtubule(GO:0000235) |
1.1 | 4.3 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 3.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.0 | 6.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.0 | 4.1 | GO:1990130 | Iml1 complex(GO:1990130) |
1.0 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 3.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.0 | 10.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.0 | 5.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 4.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 2.9 | GO:0005642 | annulate lamellae(GO:0005642) |
1.0 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 3.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 19.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.9 | 5.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.9 | 1.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.9 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 11.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.9 | 3.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 4.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 3.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.9 | 10.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.9 | 2.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 6.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.9 | 7.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.9 | 11.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.9 | 5.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.9 | 2.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.9 | 6.0 | GO:0090543 | Flemming body(GO:0090543) |
0.9 | 5.1 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 6.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.9 | 1.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.8 | 5.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 2.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 2.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.8 | 8.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.8 | 4.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.8 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 8.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 4.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 8.9 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 2.4 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 4.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 2.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 2.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.8 | 3.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 5.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 4.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.8 | 2.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.8 | 1.6 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 1.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.8 | 25.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 6.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 1.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.8 | 3.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.8 | 3.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.8 | 6.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.8 | 7.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.8 | 14.4 | GO:0030904 | retromer complex(GO:0030904) |
0.8 | 11.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 8.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.7 | 4.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 3.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 16.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 13.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.7 | 5.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 5.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.7 | 31.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.7 | 2.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 2.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 3.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.7 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.7 | 9.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 14.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.7 | 5.3 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 3.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 2.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 9.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.7 | 4.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.6 | 4.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.6 | 5.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 3.8 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 5.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.6 | 7.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 3.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.6 | 3.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 2.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 9.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.6 | 3.7 | GO:0005776 | autophagosome(GO:0005776) |
0.6 | 3.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.6 | 3.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 2.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 1.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 6.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 3.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.6 | 3.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.6 | 6.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 12.5 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.6 | 20.1 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 5.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.6 | 4.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 5.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.6 | 2.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 4.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 2.8 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 6.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 6.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 2.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 1.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 2.8 | GO:0071010 | prespliceosome(GO:0071010) |
0.6 | 2.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 1.7 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 3.3 | GO:0051286 | cell tip(GO:0051286) |
0.6 | 3.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 5.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.5 | 1.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 4.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 2.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 10.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 1.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.5 | 4.2 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.5 | 6.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 5.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 1.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.5 | 9.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 4.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.5 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 4.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.5 | 2.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 7.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.5 | 12.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 15.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 5.5 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 42.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 1.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 11.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 1.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 2.5 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 12.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 4.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.5 | 0.5 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.5 | 4.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.5 | 2.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 5.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 2.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.5 | 1.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 1.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 6.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.5 | 1.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 3.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 10.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 4.0 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 19.4 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 4.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.4 | 3.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 4.7 | GO:0030496 | midbody(GO:0030496) |
0.4 | 2.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 5.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 1.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 3.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 5.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 3.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 5.4 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.2 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 34.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.4 | 3.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 26.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.4 | 1.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 2.4 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.4 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 4.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 5.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 3.8 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.4 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 4.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 10.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 119.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 1.9 | GO:0000801 | central element(GO:0000801) |
0.4 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 4.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.4 | 1.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 1.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 15.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 14.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 2.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 1.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 11.4 | GO:0005844 | polysome(GO:0005844) |
0.3 | 2.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 2.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 3.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 3.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 10.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 4.5 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.3 | 1.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 13.4 | GO:0005819 | spindle(GO:0005819) |
0.3 | 2.8 | GO:0030894 | replisome(GO:0030894) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 18.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.9 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.3 | 3.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 5.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 18.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.3 | 1.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 1.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 3.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 1.4 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 2.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 2.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 1.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 2.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 5.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 9.4 | GO:0016605 | PML body(GO:0016605) |
0.3 | 2.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 32.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 1.3 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.3 | 0.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 3.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.3 | 3.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 24.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 6.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 67.2 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 0.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 7.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 238.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 2.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 9.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 14.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 2.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 2.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 15.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.7 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 5.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 3.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 16.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 0.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.3 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 5.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 4.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 5.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 6.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 10.0 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 3.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 5.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 4.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 69.7 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 4.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 2.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 15.0 | GO:0044451 | nucleoplasm part(GO:0044451) |
0.2 | 133.4 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 5.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.5 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.2 | 12.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 110.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 3.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 13.0 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 1.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.6 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 1.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 3.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 14.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 54.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 13.0 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 122.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 8.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 1.2 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 4.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.7 | 8.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
2.7 | 8.0 | GO:1990188 | euchromatin binding(GO:1990188) |
2.7 | 8.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.4 | 7.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.4 | 7.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.2 | 6.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
2.2 | 6.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
2.2 | 10.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
2.1 | 8.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.9 | 11.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.9 | 7.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.8 | 9.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.8 | 5.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.8 | 5.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.8 | 7.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.8 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.8 | 7.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.8 | 5.3 | GO:0019961 | interferon binding(GO:0019961) |
1.7 | 10.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.7 | 6.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.7 | 5.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.7 | 5.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.7 | 6.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.6 | 4.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.6 | 4.7 | GO:0004359 | glutaminase activity(GO:0004359) |
1.5 | 4.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.5 | 7.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.5 | 6.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.5 | 6.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.5 | 4.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.5 | 7.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.5 | 5.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.5 | 7.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.4 | 5.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.4 | 2.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.4 | 5.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.4 | 4.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.4 | 4.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.4 | 4.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.4 | 4.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.4 | 4.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.4 | 2.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.3 | 5.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.3 | 4.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 4.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.3 | 5.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.3 | 14.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.3 | 9.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.3 | 5.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.3 | 5.2 | GO:0036033 | mediator complex binding(GO:0036033) |
1.3 | 3.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.2 | 7.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.2 | 3.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.2 | 4.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.2 | 4.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.2 | 6.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.2 | 3.6 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 8.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.2 | 6.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.2 | 7.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.2 | 4.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.2 | 4.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.1 | 10.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.1 | 3.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.1 | 3.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 4.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.1 | 3.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 3.2 | GO:0051870 | methotrexate binding(GO:0051870) |
1.1 | 3.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 3.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 9.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.1 | 2.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.1 | 3.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.1 | 3.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.0 | 17.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.0 | 1.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.0 | 3.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.0 | 6.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
1.0 | 3.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.0 | 3.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 6.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
1.0 | 9.1 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 10.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 21.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.0 | 3.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.0 | 4.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.0 | 10.8 | GO:0034882 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
1.0 | 3.9 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.0 | 19.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.0 | 1.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.0 | 3.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 7.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 2.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 1.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.9 | 5.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.9 | 4.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.9 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.9 | 2.8 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.9 | 5.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.9 | 2.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.9 | 12.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.9 | 3.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.9 | 2.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.9 | 2.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 1.8 | GO:0030519 | snoRNP binding(GO:0030519) |
0.9 | 3.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.9 | 3.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 7.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.9 | 2.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.9 | 2.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.9 | 1.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.9 | 2.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.9 | 2.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.9 | 14.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 8.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.9 | 4.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.9 | 6.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.9 | 6.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.9 | 6.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.9 | 8.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.8 | 3.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 2.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 1.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.8 | 2.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.8 | 5.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.8 | 1.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 2.5 | GO:0070061 | fructose binding(GO:0070061) |
0.8 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.8 | 1.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 4.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.8 | 1.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 10.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 7.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 3.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 1.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 4.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.8 | 8.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 1.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 3.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.8 | 1.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 2.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 3.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.8 | 12.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.8 | 3.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.8 | 16.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 3.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.8 | 6.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.8 | 2.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.8 | 3.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 3.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.8 | 2.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.8 | 3.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.8 | 4.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 3.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 1.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.8 | 3.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 1.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.8 | 7.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 3.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 0.7 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.7 | 21.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 2.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 2.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.7 | 2.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.7 | 2.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.7 | 8.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 3.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 2.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.7 | 4.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 4.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 5.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.7 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 4.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.7 | 2.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 1.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.7 | 4.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 2.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.7 | 2.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.7 | 0.7 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.7 | 1.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.7 | 4.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 5.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.7 | 17.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 3.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.7 | 9.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 2.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.7 | 6.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 3.4 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 4.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 2.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 2.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.7 | 2.7 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 2.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 3.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 6.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 0.6 | GO:0015250 | water channel activity(GO:0015250) |
0.6 | 2.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 1.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 12.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 1.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 7.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 3.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 2.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 3.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.6 | 21.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 1.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 3.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 4.9 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.6 | 12.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 3.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 16.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 2.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 6.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 5.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 4.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.6 | 2.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.6 | 1.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 0.6 | GO:0032564 | dATP binding(GO:0032564) |
0.6 | 0.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 1.7 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.6 | 2.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 2.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 16.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.6 | 4.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 4.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 1.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 1.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 6.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 10.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 2.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 0.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 3.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 4.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.5 | 4.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 10.2 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 3.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 1.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 4.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 2.6 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.5 | 15.8 | GO:0061733 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.5 | 10.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 14.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 7.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 1.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 3.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 1.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 6.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 2.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 3.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 7.0 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 4.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.5 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 9.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 2.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.5 | 9.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.5 | 1.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 17.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.5 | 4.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.5 | 5.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 14.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.5 | 3.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 4.3 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 14.7 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.5 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 1.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 6.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 3.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 1.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 3.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 6.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 2.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.5 | 8.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 3.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.5 | 5.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 9.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 7.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 3.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 4.9 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 2.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 6.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 1.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 18.6 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 5.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 8.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 7.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 13.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.4 | 8.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 2.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 30.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 5.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.4 | 1.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 12.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 5.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 7.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 3.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 5.5 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 1.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 8.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 0.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 12.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 9.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 7.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 12.3 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 2.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.4 | 0.4 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.4 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 5.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 11.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 7.8 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.4 | 1.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 1.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 4.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 3.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 2.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 4.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 1.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.4 | 9.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 5.6 | GO:0019825 | oxygen binding(GO:0019825) |
0.4 | 2.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 3.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 1.5 | GO:0043731 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.4 | 3.0 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 3.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 1.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.4 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 0.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 3.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 2.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 10.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 5.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 3.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 3.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.7 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.3 | 11.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 43.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 2.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 0.3 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.3 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 7.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 4.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 4.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 17.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 10.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 4.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 8.8 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 5.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 0.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.3 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 6.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 2.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 5.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 1.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 36.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 0.7 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 0.3 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.3 | 1.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 12.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 2.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 4.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 2.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 27.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 0.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 4.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 0.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 2.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 15.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 1.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 6.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 5.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.3 | GO:0016671 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.3 | 3.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 1.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.3 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 7.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 0.9 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 2.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 21.6 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.3 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 18.5 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.3 | 5.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 3.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 50.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 3.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 2.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 5.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 1.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 4.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 1.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 2.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 3.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 2.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 1.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 1.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 1.3 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 0.8 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 4.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.5 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 1.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 1.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 2.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 4.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 2.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 2.0 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 1.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 3.3 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.2 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 4.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 7.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 6.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 5.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 2.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 5.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 7.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 1.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.0 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 4.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 0.6 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 4.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 2.0 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 9.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 3.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 1.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.6 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.2 | 1.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 2.7 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 3.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 10.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 2.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 4.7 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 5.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 1.8 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 2.8 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 0.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 4.4 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.0 | GO:0008233 | peptidase activity(GO:0008233) |
0.2 | 15.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 3.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 2.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 2.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 87.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 10.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 0.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 5.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 0.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 1.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 3.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 2.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 4.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 11.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 2.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 2.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 2.8 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 4.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 10.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 3.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 9.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.8 | GO:0090484 | drug transporter activity(GO:0090484) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.7 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 3.0 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 1.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 12.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 21.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 4.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 6.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.5 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 2.5 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 3.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 2.1 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.8 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.6 | GO:0046943 | carboxylic acid transmembrane transporter activity(GO:0046943) |
0.0 | 0.1 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 1.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 12.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.3 | 6.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 8.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.9 | 12.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 5.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 34.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 29.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.8 | 23.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.8 | 32.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 8.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 15.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 15.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 44.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 22.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 10.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.7 | 11.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 21.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 18.4 | PID FOXO PATHWAY | FoxO family signaling |
0.7 | 12.9 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 9.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.7 | 7.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 29.1 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 5.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 2.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 4.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 5.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 8.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 6.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 15.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 6.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 8.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 6.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.5 | 11.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 5.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 5.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 4.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 3.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 6.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 8.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 3.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 3.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 3.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 4.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 5.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 6.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 7.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 10.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 1.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 2.1 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 4.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 10.8 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 8.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 4.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 2.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 7.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 6.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 3.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 3.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 4.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 2.6 | PID ATM PATHWAY | ATM pathway |
0.2 | 4.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 3.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 4.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 5.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 6.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 6.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 4.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 20.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.3 | 11.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.3 | 2.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.3 | 15.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.2 | 20.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.2 | 6.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.1 | 2.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.1 | 5.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.1 | 4.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.0 | 27.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.0 | 8.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.0 | 14.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.0 | 14.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 32.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.0 | 5.9 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
1.0 | 3.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 1.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.9 | 0.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.9 | 12.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.9 | 9.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.9 | 12.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 12.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 8.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 5.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 10.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 8.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.8 | 8.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.8 | 6.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.8 | 11.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.8 | 11.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 17.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 20.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 5.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 4.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.7 | 2.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.7 | 4.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 7.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.7 | 4.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 10.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.7 | 2.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.6 | 12.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.6 | 10.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.6 | 8.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.6 | 6.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 6.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 6.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 5.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 8.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 11.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 19.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.6 | 2.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 4.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 4.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.6 | 4.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 11.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 6.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 37.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 1.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 8.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 4.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.5 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 3.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 9.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 21.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.5 | 6.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 13.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 6.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.5 | 6.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 19.1 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.5 | 9.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.5 | 7.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.5 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.5 | 6.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 7.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 1.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.5 | 2.4 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.5 | 21.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 5.6 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.5 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 6.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 20.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 3.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 4.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 9.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.4 | 6.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 10.4 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.4 | 3.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 6.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 8.2 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.4 | 8.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 5.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 8.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.4 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 6.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 8.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.4 | 5.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 7.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 3.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 8.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 7.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 4.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 3.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 0.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 2.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 4.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 7.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 7.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 7.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 9.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 33.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 2.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 4.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 1.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.4 | 4.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 2.9 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.4 | 3.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 8.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 4.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 3.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 4.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 5.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 2.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 4.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 3.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.3 | 3.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 2.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 10.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 1.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 11.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 16.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 7.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 16.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 4.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 3.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 1.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 0.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 2.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 6.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 5.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 4.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 1.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 8.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 7.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 2.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 13.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 6.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 2.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 3.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 0.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.2 | 2.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 1.0 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 1.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 6.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 5.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 8.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 4.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 2.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.5 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.2 | 3.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 19.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 1.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 6.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.6 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |